Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyBCBS Rhode Island New Technology Coverage | OpenPa…
    Ask Trek AI about this page
    DraftBlue Cross Blue Shield - Rhode IslandPolicy N/A

    New Technology and Miscellaneous Services

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts

    Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy establishes coverage categories and administrative requirements for CPT codes representing new, emerging, and existing unproven technologies for Medicare Advantage and Commercial Products in Rhode Island.

    Policy Summary
    PayerBlue Cross Blue Shield - Rhode Island
    PolicyNew Technology and Miscellaneous Services
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJan 1, 202745d
    Last ReviewApr 1, 2026
    Next Review DateN/A
    Key ActionFor services requiring prior authorization, consult the related policies identified in the Code and Coverage Grid for the applicable medical criteria.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    2Product segments addressed
    7Primary-care specialties with exemption
    Category AMedicare Advantage device category not covered
    Category BMedicare Advantage device category potentially covered

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Coverage Criteria

    For Medicare Advantage, FDA Category A investigational devices are considered not medically reasonable and necessary and are therefore not covered. Category A status applies when the absolute risk of the device type has not been established and initial safety and effectiveness questions remain unresolved.

    When a Category III code is archived without conversion to a Category I code, the related service or procedure must be reported using a Category I unlisted code, unless a specific cross-reference is established at the time of archiving.

    A treatment or procedure is not medically necessary when reliable evidence shows that prevailing expert opinion requires additional studies or clinical trials to establish its safety, efficacy, toxicity, maximum tolerated dose, or efficacy compared with a standard treatment or diagnosis.

    For Commercial Products, a service may be classified as not medically necessary when available evidence is insufficient to determine the technology’s effects on health outcomes.

    Prior Authorization and Provider Requirements

    Prior Authorization

    Prior Authorization and Primary-Care Exemption

    For services requiring prior authorization, consult the Related Policies identified in the Code and Coverage Grid for the applicable medical-necessity criteria. Effective 10/1/2025, prior authorization may not be needed for Fully-Funded Commercial Products when requested by a BCBSRI Contracted Primary Care Provider in an eligible specialty; authorization remains required for SelfFunded Commercial Products, Medicare Advantage Plans, and other non-exempt situations.

    • Eligible credentialed primary-care specialties: Internal Medicine; Pediatric Medicine; Family Practice; Obstetrics and Gynecology; Doctor of Osteopathic Medicine; NP (Nurse Practitioner)/PCP (Primary Care Physician or Provider); and PA (Physician Assistant).
    • Always verify the product type, provider contract status, credentialed specialty, and Related Policies before relying on the exemption.
    Denial Risk

    Insufficient Evidence or Category A Device

    Commercial coverage may be denied as not medically necessary when evidence is insufficient to determine the technology’s effects on health outcomes. For Medicare Advantage, FDA Category A experimental devices are not medically reasonable and necessary and are therefore not covered.

    • Commercial coverage categories may include: Not medically necessary because evidence is insufficient to determine effects on health outcomes; preauthorization recommended; not separately reimbursed; or use alternate procedure code.
    • Category A devices are experimental devices for which absolute risk has not been established and initial safety and effectiveness questions remain unresolved.
    • Category B devices may be covered when medically reasonable and necessary and all other applicable Medicare coverage requirements are met.
    Denial Risk

    Unresolved Clinical Evidence

    A treatment or procedure is not medically necessary when reliable evidence shows that the prevailing expert opinion requires additional studies or clinical trials to determine its safety, efficacy, toxicity, maximum tolerated dose, or efficacy compared with a standard treatment or diagnostic method.

    • Expect denial when reliable evidence indicates that further studies are needed to establish the treatment or procedure’s clinical safety or effectiveness.
    • Medical necessity also requires consistency with the diagnosis and generally accepted professional standards of care, that the service is not primarily for convenience, and that it is furnished at the safest appropriate level of care.

    Policy Background

    This policy primarily addresses CPT Category III temporary codes for emerging technologies, services, and procedures. These codes support identification and collection of data related to clinical efficacy, utilization, and outcomes. Category III status alone does not establish or reject clinical efficacy, safety, applicability to clinical practice, or payer coverage.

    Definitions

    Category III CPT code
    DefinitionTemporary CPT codes for emerging technology, services, and procedures.
    PurposeAllow data collection for these services and procedures.
    UsesSupport identification of emerging technologies, services, and procedures for clinical efficacy, utilization, and outcomes analysis.
    Category A investigational device
    DefinitionAn FDA Category A experimental device for which the absolute risk of the device type has not been established.
    Evidence statusInitial questions of safety and effectiveness have not been resolved.
    Medicare Advantage coverage
    Policy Summary
    PayerBlue Cross Blue Shield - Rhode Island
    PolicyNew Technology and Miscellaneous Services
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJan 1, 202745d
    Last ReviewApr 1, 2026
    Next Review DateN/A
    Key ActionFor services requiring prior authorization, consult the related policies identified in the Code and Coverage Grid for the applicable medical criteria.
    SourceLink
    On This Page
    Coverage CriteriaPrior Authorization and Provider RequirementsPolicy BackgroundDefinitions
    Considered not medically reasonable and necessary and therefore not covered.
    Category B device
    DefinitionAn FDA Category B non-experimental/investigational device for which incremental risk is the primary risk in question.
    Evidence statusInitial questions of safety and effectiveness for the device type have been resolved, or the device type is known to be safe and effective.
    Medicare Advantage coverageMay be covered when medically reasonable and necessary and all other applicable Medicare coverage requirements are met.